ESMO 2026 - Breast Cancer: Targeting B7-H3 with Dr. Hongxia Wang

Dr. Hongxia Wang of Fudan University Shanghai Cancer Center takes us inside a phase 1/2 study of a B7-H3-targeting ADC in advanced breast cancer, exploring its design and the next steps in clinical development.